Inhaled Nicotine Disrupts Normal Heart Function
THURSDAY, Oct. 24, 2024 -- Nicotine delivered by either chronic electronic cigarettes or standard cigarettes disrupts normal heart function, according to a study published online Sept. 11 in the Journal of the American Heart Association.
Rashid Alavi, Ph.D., from the University of Southern California in Los Angeles, and colleagues assessed whether the novel intrinsic frequency (IF) metrics derived from carotid pressure waveforms can detect effects of nicotine (from chronic exposure to electronic cigarette vapor or traditional cigarette smoke) on the cardiovascular system. The analysis included 117 healthy adult male and female rats.
The researchers found that standard cigarettes significantly increased the first IF (indicating left ventricle contractile dysfunction). There was a significant reduction in the second IF with electronic cigarettes with nicotine, indicating adverse effects on vascular function. There were no significant differences in the IF metrics between controls and electronic cigarettes without nicotine. There was a significant increase in the total IF variation with exposure to electronic cigarettes with nicotine, suggesting adverse effects on left ventricle–arterial coupling and its optimal state versus electronic cigarettes without nicotine.
"Our results support the growing call for public health policies aimed at reducing exposure to inhaled nicotine and to new synthetic nicotine products not yet on the market," coauthor Michael Kleinman, Ph.D., from the University of California, Irvine, said in a statement. "APHEL hopes to further unravel the connection between inhaled environmental toxins and heart disease, contributing to safer, healthier communities."
One author disclosed ties to Ventric Health.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Prevention Strategies Developed for Cardiovascular Manifestations of COVID
FRIDAY, Sept. 26, 2025 -- Prevention strategies for cardiovascular manifestations of acute and long COVID are discussed in a report published online Sept. 18 in the European...
Cocoa Extract Supplementation Yields Significant Reduction in hsCRP
WEDNESDAY, Sept. 24, 2025 -- Cocoa extract supplementation yields a significant reduction in high-sensitivity C-reactive protein (hsCRP) and an increase in interferon-&gamma...
Only 36.4 Percent of U.S. Adults Had No CVD Risk Factors in Recent Years
WEDNESDAY, Sept. 24, 2025 -- During August 2021 to August 2023, only 36.4 percent of U.S. adults had no cardiovascular disease (CVD) risk factors, according to a September data...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.